Spontaneous proximal deep vein thrombosis in a patient with severe haemophilia A

Blood Coagulation and Fibrinolysis

Volumn 14, Issue 4, 2003, Pages 407-409

  Dargaud, Yesim ^a   Cruchaudet, Battistina Buono ^a   Lienhart, Anne ^a   Coppéré, Brigitte ^a   Ninet, Jacques ^a   Négrier, Claude ^a  

^a EDOUARD HERRIOT HOSPITAL   (France)

Author keywords

Deep vein thrombosis; Haemophilia; HIV infection

Indexed keywords

ANTICOAGULANT AGENT; HEPARIN; RECOMBINANT BLOOD CLOTTING FACTOR 8;

ABDOMINAL RADIOGRAPHY; ADULT; ANAMNESIS; ANTICOAGULANT THERAPY; ARTICLE; BONE MARROW BIOPSY; CANCER SCREENING; CARDIOVASCULAR RISK; CASE REPORT; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; DEEP VEIN THROMBOSIS; DISEASE SEVERITY; DOPPLER FLOWMETRY; FEMORAL VEIN; HEMOPHILIA A; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT OUTCOME;

ADULT; FACTOR VIII; FEMORAL VEIN; HEMOPHILIA A; HEPARIN, LOW-MOLECULAR-WEIGHT; HUMANS; MALE; TOMOGRAPHY, X-RAY COMPUTED; VENOUS THROMBOSIS;

EID: 0037832618     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-200306000-00013     Document Type: Article

References (21)

1. 506 Gln (factor V Leiden). Haemophilia 2000; 6:631-634.
2. Ritchie B, Woodman RC, Poon MC. Deep vein thrombosis in hemophilia A. Am J Med 1992; 93:699-700.
3. Ettingshausen E, Martinez Saguer I, Kreuz W. Portal vein thrombosis in a patient with severe hemophilia A and FV G1691A mutation during continuous infusion of FVIII after intramural jejunal bleeding - successful thrombolysis under heparin therapy. Eur J Pediatr 1999; 158(suppl 3): S180-S182.
4. Van der Planken MG, Schroyens W, Vertessen F, Michiels JJ, Berneman ZN. Distal deep venous thrombosis in a hemophilia A patient with inhibitor and severe infectious disease, 18 days after recombinant activated factor VII transfusion. Blood Coagul Fibrinolysis 2002; 13:367-370.
5. Peerlinck K, Vermylen J. Acute myocardial infarction following administration of recombinant activated factor VII (Novoseven) in a patient with hemophilia A and inhibitor. Thromb Haemost 1999; 82:1775-1776.
6. Köhler M. Thrombogenicity of prothrombin complex concentrates. Thromb Res 1999; 95:S13-S17.
7. Stewart AJ, Manson LM, Dennis R, Allan PL, Ludlam CA. Thrombosis in a duplicated superficial femoral vein in a patient with hemophilia A. Haemophilia 2000; 6:47-49.
8. Lee DH, Walker IR, Teitel J, Poon MC, Ritchie B, Akabutu J, et al. Effect of the factor V Leiden mutation on the clinical expression of severe hemophilia A. Thromb Haemost 2000; 83:387-391.
9. Negrier C, Vial J, Vinciguerra C, Berruyer M, Dechavanne M. Combined factor IX and protein C deficiency in a child: thrombogenic effects of two factor IX concentrates. Am J Hematol 1995; 48:120-124.
10. Tizzano EF, Cornet M, Domenech M, Baiget M. Modifier genes in hemophilia: their expansion in the human genome. Hemophilia 2002; 8:250-254.
11. De Gaetano Donati K, Tacconelli E; Scoppettuolo G, De Stefano V, Cauda R, Tumbarello M. Recurrent venous thrombosis in a patient with haemophilia A and HIV infection [e-case]. Haematologica 2002; 87:ECR04.
12. Saif MW, Bona R, Greenberg B. AIDS and thrombosis: retrospective study of 131 HIV-infected patients. AIDS Patient Care STDS 2001; 15:311-320.
13. Saif MW, Greenberg B. HIV and thrombosis: a review. AIDS Patient Care STDS 2001; 15:15-24.
14. Leder AN, Flansbaum B, Zandman-Goddard G, Asherson R, Shoenfeld Y. Antiphospholipid syndrome induced by HIV. Lupus 2001; 10:370-374.
15. Stahl CP, Wideman CS, Spira TJ, Haff EC, Hixon GJ, Evatt BL. Protein S deficiency in men with long term human immunodeficiency virus infection. Blood 1993; 81:1801-1807.
16. Sahud MA, Claster S, Liu L, Ero M, Harris K, Furlan M. Von Willebrand factor - cleaving protease inhibitor in a patient with human immunodeficiency syndrome-associated thrombotic thrombocytopenic purpura. Br J Haematol 2002; 116:909-911.
17. Lafeuillade A, Alessi MC, Poizot-Martin I, Boyer-Neumann C, Zandotti C, Quilichini R et al. Endothelial cell dysfunction in HIV infection. J Acquir Immune Defic Syndr 1992; 5:127-131.
18. Seigneur M, Constans J, Blann A, Renard M, Pellegrin JL, Amiral J, et al. Soluble adhesion molecules and endothelial cell damage in HIV infected patients. Thromb Haemost 1997; 77:646-649.
19. Lewis W. Atherosclerosis in AIDS: potential pathogenetic roles of antiretroviral therapy and HIV. J Mol Cell Cardiol 2000; 32:2115-2129.
20. Carr A, Brown D, Cooper DA. Portal vein thrombosis in patients receiving indinavir, an HIV protease inhibitor. AIDS 1997; 11:1657-1658.
21. Esmon CT. Does inflammation contribute to thrombotic events? Haemostasis 2000; 30(suppl 2):34-40.